An electronic quality management system (eQMS) digitises the processes of the pharmaceutical quality system: deviations, CAPA, change control, OOS and lab investigations, internal and supplier audits, risk management, document control and training. Each process becomes a controlled workflow with defined roles, approvals, due dates and an audit trail.
The value of an eQMS lies in the links between records. A deviation raises a CAPA; an audit observation raises another; a changed SOP triggers training; a supplier audit updates the supplier’s qualification. On paper those links depend on cross-references typed by hand. In an eQMS they are part of the record.
Why it matters in GMP
ICH Q10 describes a pharmaceutical quality system built on process performance and product quality monitoring, CAPA, change management and management review. Regulators expect manufacturers to show that these processes work together and that management can see the state of quality — open investigations, overdue actions, recurring problems — at any time.
- One numbering scheme and one audit trail across all quality records.
- Overdue actions visible to owners and managers without chasing.
- Evidence for the product quality review and inspections available on demand.
How Swat iQua Suite handles it
Swat iQua Suite covers CAPA, deviations, change control, OOS and lab quality events, internal, external and supplier audits, FMEA-based risk management, supplier qualification, SOPs and training on one platform, with server-enforced segregation of duties and per-site e-signatures. A role-based Action Center shows each person’s pending reviews, approvals and due dates, and a daily digest emails overdue items. Because the eQMS shares records with the LIMS and eBMR, open deviations, OOS and CAPAs block the batch release checklist directly.